Condition: Hepatitis C · Sponsor: Landspitali University Hospital
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
This description comes directly from the study's public registry record.
Ragnheidur Fridriksdottir, B.Sc, MA · + 354 543 6096 · ragnhefr@landspitali.is
Halla Arnardottir, B Sc · +354 5435711 · hallarn@landspitali.is
Always discuss trial participation with your own doctor first.
| Landspitali | Reykjavik, Iceland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02647879